Nanoparticle-Integrated Transdermal Patches: A Platform for Next-Generation Drug Delivery

Area of Science:

• Pharmaceutical Sciences
• Biotechnology
• Materials Science

Background:

• Transdermal drug delivery systems (TDDS) offer noninvasive administration, but skin's stratum corneum limits drug penetration.
• Nanoparticle-mediated TDDS can overcome these limitations, enhancing drug permeation and bioavailability.
• Current research focuses on optimizing nanocarrier formulations for improved drug loading, release, and skin interaction.

Purpose of the Study:

• To review various nanocarriers and innovative technologies for transdermal drug delivery.
• To analyze formulation characteristics influencing the efficacy and stability of nanoparticle-integrated patches.
• To identify translational challenges and future research directions for nanoparticle-based TDDS.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies on nanoparticle-mediated transdermal systems.
• Analysis of different nanocarrier types (liposomes, SLNs, NLCs, etc.) and their impact on drug delivery.
• Examination of formulation components (polymers, enhancers) and advanced delivery platforms (microneedles, 3D printing).

Main Results:

• Nanocarriers can increase drug permeability by 2- to 10-fold and drug retention in the epidermis by 3- to 5-fold.
• Entrapment efficiencies up to 90% and sustained drug release up to 72 hours have been achieved.
• Innovative systems like microneedles and 3D-printed patches show potential for enhanced dosage accuracy and efficacy.

Conclusions:

• Nanoparticle-based transdermal systems demonstrate significant potential for improved drug delivery, bioavailability, and patient adherence.
• Key challenges include regulatory approval, safety assessment, and scalable Good Manufacturing Practice (GMP) production.
• Further research in pharmacokinetic modeling, human skin correlation, and stability studies is crucial for clinical translation.